User profiles for E. Warner

Ellen Warner

- Verified email at sunnybrook.ca - Cited by 25621

Erica T. Warner

- Verified email at mgh.harvard.edu - Cited by 6149

American cancer society/American society of clinical oncology breast cancer survivorship care guideline

…, LB Marks, SJ LaMonte, E Warner… - CA: a cancer journal …, 2016 - Wiley Online Library
… No part of this document may be reproduced or transmitted in any form or by any means,
electronic or mechanical, including photocopy, recording, or any information storage and …

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer

E Warner, H Messersmith, P Causer… - Annals of internal …, 2008 - acpjournals.org
… After reviewing the titles and abstracts of 217 articles identified in the electronic search and
removing duplicates, we selected 40 for full-text review. Of these, we identified 11 articles (22…

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

…, DA Haber, JP Struewing, E Warner… - Nature …, 1996 - pubmed.ncbi.nlm.nih.gov
… 1 , B Weber, K Offit, F Couch, TR Rebbeck, S Neuhausen, AK Godwin, M Daly, J Wagner-Costalos,
D Berman, G Grana, E Fox, MF Kane, RD Kolodner, M Krainer, DA Haber, JP Struewing, E …

[PDF][PDF] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined …

…, N Tang, E Olah, H Anton-Culver, E Warner… - The American Journal of …, 2003 - cell.com
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer,
but the average magnitude of these risks is uncertain and may depend on the context. …

[HTML][HTML] Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

…, CG Guo, W Ma, RS Mehta, ET Warner… - The Lancet Public …, 2020 - thelancet.com
Background Data for front-line health-care workers and risk of COVID-19 are limited. We
sought to assess risk of COVID-19 among front-line health-care workers compared with the …

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

…, S Sener, RA Smith, E Warner… - CA: a cancer journal …, 2007 - Wiley Online Library
New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available
since the American Cancer Society (ACS) last issued guidelines for the early detection of …

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

E Warner, DB Plewes, KA Hill, PA Causer, JT Zubovits… - Jama, 2004 - jamanetwork.com
ContextCurrent recommendations for women who have a BRCA1 or BRCA2 mutation are to
undergo breast surveillance from age 25 years onward with mammography annually and …

[HTML][HTML] Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for …

…, D Fischer, H Forstbauer, R Liersch, E Warner… - Annals of …, 2021 - Elsevier
Background In the phase III IMpassion130 trial, combining atezolizumab with first-line
nanoparticle albumin-bound-paclitaxel for advanced triple-negative breast cancer (aTNBC) …

Patient preferences for oral versus intravenous palliative chemotherapy.

G Liu, E Franssen, MI Fitch, E Warner - Journal of Clinical Oncology, 1997 - ascopubs.org
PURPOSE To assess patient preference for oral versus intravenous (iv) palliative chemotherapy
(CT). A strong preference would be an important quality-of-life issue. PATIENTS AND …

Interrupting endocrine therapy to attempt pregnancy after breast cancer

…, JR Kroep, A Mailliez, E Warner… - New England journal …, 2023 - Mass Medical Soc
Background Prospective data on the risk of recurrence among women with hormone
receptor–positive early breast cancer who temporarily discontinue endocrine therapy to attempt …